CCP Approves CDC Investment in NCMCL Under Competition Act Review

Approves CDC’s Investment in NCMCL

The (CCP) has approved the proposed investment by Central Depository Company of Pakistan Limited (CDC) in Naymat Collateral Management Company Limited (NCMCL). This decision follows a Phase-I review under the 2010 Competition Act.

CDC, established in 1993, is one of Pakistan’s key capital market institutions. It provides electronic custody of securities and settlement facilitation services. NCMCL, incorporated in 2020, operates as a collateral management company overseeing warehouses for commodities held as collateral.

The CCP concluded that the deal would not significantly alter competition dynamics or create entry barriers. The transaction was also deemed unlikely to result in anti-competitive effects such as market foreclosure or collusion.